VISTAGEN THERAPEUTICS, INC. Total Liabilities and Equity
VISTAGEN THERAPEUTICS, INC. (VTGN) had Total Liabilities and Equity of $35.74 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-14
- 2026-06-30: Liabilities and Equity $35.74M.
- 2026-03-31: Liabilities and Equity $48.56M.
- 2025-12-31: Liabilities and Equity $65.06M.
- 2025-09-30: Liabilities and Equity $80.93M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $35.74M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $48.56M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $65.06M 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $80.93M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $68.92M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $84.34M 10-K · filed 2026-06-15 | |
| 2024-12-31 | $92.31M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $102.50M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $113.55M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $123.65M 10-K · filed 2025-06-17 | |
| 2023-12-31 | $131.07M 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $42.20M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $15.03M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $21.09M 10-K · filed 2024-06-11 | $21.09M 10-K · filed 2023-06-28 |
| 2022-12-31 | $29.71M 10-Q · filed 2023-02-07 | |
| 2022-09-30 | $40.70M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $58.73M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $74.64M 10-K · filed 2023-06-28 | |
| 2021-12-31 | $90.54M 10-Q · filed 2022-02-10 | |
| 2021-09-30 | $100.50M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $103.91M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $108.28M 10-K · filed 2022-06-23 | |
| 2020-12-31 | $109.27M 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $20.27M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $6.17M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $5.77M 10-K · filed 2021-06-29 | |
| 2019-12-31 | $5.33M 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $8.74M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $12.95M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $14.01M 10-K · filed 2020-06-29 | |
| 2018-12-31 | $7.52M 10-Q · filed 2019-02-12 | |
| 2018-09-30 | $8.89M 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $8.26M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $11.28M 10-K · filed 2019-06-25 | |
| 2017-12-31 | $14.24M 10-Q · filed 2018-02-12 | |
| 2017-09-30 | $2.62M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $2.44M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $3.71M 10-K · filed 2018-06-26 | |
| 2016-12-31 | $5.88M 10-Q · filed 2017-02-13 | |
| 2016-09-30 | $7.02M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $8.76M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $989.80K 10-K · filed 2017-06-29 | |
| 2015-12-31 | $2.01M 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $1.93M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $1.74M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $269.70K 10-K · filed 2016-06-24 | |
| 2014-12-31 | $259.40K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $386.90K 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $764.70K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $263.70K 10-K · filed 2015-06-29 | |
| 2013-12-31 | $328.90K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $406.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $431.80K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $263.70K 10-Q · filed 2014-11-19 | $881.50K 10-K · filed 2013-07-18 |
| 2012-12-31 | $326.00K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $424.60K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $645.00K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $881.50K 10-Q · filed 2013-11-14 | $341.60K 10-K · filed 2012-07-02 |
| 2011-12-31 | $399.72K 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $537.29K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $1.68M 10-Q · filed 2011-08-22 | |
| 2011-03-31 | $323.60K 10-K · filed 2012-07-02 | $323.68K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |